Sessions for patients with neurological conditions are delivered with Nordoff and Robbins funding.

DEFY Neuro Rehabilitation launches during Brain Injury Awareness Month with a mission to serve families and strengthen ...

A decade ago, Doug Upton was the picture of strength as a U.S. Marine Corps officer stationed in Jordan. But in 2016, subtle warning signs emerged, indicating something wasn’t quite right. “My legs ...

As science advances, we have a better understanding how how neuroscience can inform the work of psychotherapy.

New review highlights evolving Pompe disease management, from screening to next-generation therapies and monitoring. Read ...

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

Single-center study finds no thrombosis prevention and more complications ...

News and commentary from the world of neurology and neuroscience ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

Clinical-stage biotech Alterity Therapeutics has appointed internationally recognised neurologist Dr Daniel O Claassen as Chief Medical Advisor as it advances its lead drug candidate ATH434 toward a ...

SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the b ...